AI in Healthcare
Jun 19, 2026
Resumo do dia
The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own. Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments. Pramaana Labs raises $27M seed round from Khosla Ventures to bring formal verification to AI. New research shows how AMIE, our medical AI, could help manage health conditions. Merck and Protillion ink AI drug discovery deal worth up to $510M. Protillion and Merck & Co sign AI drug discovery pact. General-purpose LLMs outperform specialized clinical AI tools. Pfizer signs licence agreement with Chai for AI drug discovery. AI Agent Failure Detection and Root Cause Analysis with Strands Evals. The researchers who built AI-generated DNA just raised $50 million to reinvent biology
Principais notícias
- 1
The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own
AI's next winners in healthcare could be companies like Eli Lilly and Twist Bioscience.
- 2
Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments
Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments Genetic Engineering and Biotechnology News
- 3
Pramaana Labs raises $27M seed round from Khosla Ventures to bring formal verification to AI
Pramaana will focus on highly sensitive verticals like law, drug discovery, and tax preparation — where errors can be costly and reliability is at a premium.
- 4
New research shows how AMIE, our medical AI, could help manage health conditions
Research in “Nature” shows our conversational AI system matches primary care physicians in complex disease management.
- 5
Merck and Protillion ink AI drug discovery deal worth up to $510M
Merck and Protillion ink AI drug discovery deal worth up to $510M Seeking Alpha
Em breve
Follow the sources below for updates.
Fontes
- The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own
- Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments
- Pramaana Labs raises $27M seed round from Khosla Ventures to bring formal verification to AI
- New research shows how AMIE, our medical AI, could help manage health conditions
- Merck and Protillion ink AI drug discovery deal worth up to $510M
- Protillion and Merck & Co sign AI drug discovery pact
- General-purpose LLMs outperform specialized clinical AI tools
- Pfizer signs licence agreement with Chai for AI drug discovery
- AI Agent Failure Detection and Root Cause Analysis with Strands Evals
- The researchers who built AI-generated DNA just raised $50 million to reinvent biology
Share this with a friend
Send today's roundup to anyone who wants to keep up.
Get daily AI news free with AIToday
200+ AI sources, summarized in 1 minute. Email / LINE / Slack.
Sign up free